298 related articles for article (PubMed ID: 19647120)
1. Anandamide and the vanilloid receptor (TRPV1).
Tóth A; Blumberg PM; Boczán J
Vitam Horm; 2009; 81():389-419. PubMed ID: 19647120
[TBL] [Abstract][Full Text] [Related]
2. Anandamide and vanilloid TRPV1 receptors.
Ross RA
Br J Pharmacol; 2003 Nov; 140(5):790-801. PubMed ID: 14517174
[TBL] [Abstract][Full Text] [Related]
3. The endovanilloid/endocannabinoid system in human osteoclasts: possible involvement in bone formation and resorption.
Rossi F; Siniscalco D; Luongo L; De Petrocellis L; Bellini G; Petrosino S; Torella M; Santoro C; Nobili B; Perrotta S; Di Marzo V; Maione S
Bone; 2009 Mar; 44(3):476-84. PubMed ID: 19059369
[TBL] [Abstract][Full Text] [Related]
4. The endogenous cannabinoid anandamide inhibits transient receptor potential vanilloid type 1 receptor-mediated currents in rat cultured primary sensory neurons.
Sántha P; Jenes A; Somogyi C; Nagy I
Acta Physiol Hung; 2010 Jun; 97(2):149-58. PubMed ID: 20511124
[TBL] [Abstract][Full Text] [Related]
5. Anandamide receptor signal transduction.
Goodfellow CE; Glass M
Vitam Horm; 2009; 81():79-110. PubMed ID: 19647109
[TBL] [Abstract][Full Text] [Related]
6. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.
Cabranes A; Venderova K; de Lago E; Fezza F; Sánchez A; Mestre L; Valenti M; García-Merino A; Ramos JA; Di Marzo V; Fernández-Ruiz J
Neurobiol Dis; 2005 Nov; 20(2):207-17. PubMed ID: 16242629
[TBL] [Abstract][Full Text] [Related]
7. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M
Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432
[TBL] [Abstract][Full Text] [Related]
8. Sperm Release From the Oviductal Epithelium Depends on Ca(2+) Influx Upon Activation of CB1 and TRPV1 by Anandamide.
Gervasi MG; Osycka-Salut C; Sanchez T; Alonso CA; Llados C; Castellano L; Franchi AM; Villalón M; Perez-Martinez S
J Cell Biochem; 2016 Feb; 117(2):320-33. PubMed ID: 26129689
[TBL] [Abstract][Full Text] [Related]
9. Transient receptor potential vanilloid 1 channels control acetylcholine/2-arachidonoylglicerol coupling in the striatum.
Musella A; De Chiara V; Rossi S; Cavasinni F; Castelli M; Cantarella C; Mataluni G; Bernardi G; Centonze D
Neuroscience; 2010 May; 167(3):864-71. PubMed ID: 20219639
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the endocannabinoid system in human spermatozoa and involvement of transient receptor potential vanilloid 1 receptor in their fertilizing ability.
Francavilla F; Battista N; Barbonetti A; Vassallo MR; Rapino C; Antonangelo C; Pasquariello N; Catanzaro G; Barboni B; Maccarrone M
Endocrinology; 2009 Oct; 150(10):4692-700. PubMed ID: 19608651
[TBL] [Abstract][Full Text] [Related]
11. Biochemistry and pharmacology of endovanilloids.
Starowicz K; Nigam S; Di Marzo V
Pharmacol Ther; 2007 Apr; 114(1):13-33. PubMed ID: 17349697
[TBL] [Abstract][Full Text] [Related]
12. Anandamide in primary sensory neurons: too much of a good thing?
Sousa-Valente J; Varga A; Ananthan K; Khajuria A; Nagy I
Eur J Neurosci; 2014 Feb; 39(3):409-18. PubMed ID: 24494681
[TBL] [Abstract][Full Text] [Related]
13. Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol.
Spoto B; Fezza F; Parlongo G; Battista N; Sgro' E; Gasperi V; Zoccali C; Maccarrone M
Biochimie; 2006 Dec; 88(12):1889-97. PubMed ID: 16949718
[TBL] [Abstract][Full Text] [Related]
14. TRPV1 Activation by Anandamide via a Unique Lipid Pathway.
Muller C; Lynch DL; Hurst DP; Reggio PH
J Chem Inf Model; 2021 Dec; 61(12):5742-5746. PubMed ID: 34780173
[TBL] [Abstract][Full Text] [Related]
15. Endocannabinoids activate transient receptor potential vanilloid 1 receptors to reduce hyperdopaminergia-related hyperactivity: therapeutic implications.
Tzavara ET; Li DL; Moutsimilli L; Bisogno T; Di Marzo V; Phebus LA; Nomikos GG; Giros B
Biol Psychiatry; 2006 Mar; 59(6):508-15. PubMed ID: 16199010
[TBL] [Abstract][Full Text] [Related]
16. Why do cannabinoid receptors have more than one endogenous ligand?
Di Marzo V; De Petrocellis L
Philos Trans R Soc Lond B Biol Sci; 2012 Dec; 367(1607):3216-28. PubMed ID: 23108541
[TBL] [Abstract][Full Text] [Related]
17. Anandamide-induced behavioral disruption through a vanilloid-dependent mechanism in rats.
Panlilio LV; Mazzola C; Medalie J; Hahn B; Justinova Z; Drago F; Cadet JL; Yasar S; Goldberg SR
Psychopharmacology (Berl); 2009 Apr; 203(3):529-38. PubMed ID: 19015836
[TBL] [Abstract][Full Text] [Related]
18. Organized trafficking of anandamide and related lipids.
Yates ML; Barker EL
Vitam Horm; 2009; 81():25-53. PubMed ID: 19647107
[TBL] [Abstract][Full Text] [Related]
19. Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret.
Sharkey KA; Cristino L; Oland LD; Van Sickle MD; Starowicz K; Pittman QJ; Guglielmotti V; Davison JS; Di Marzo V
Eur J Neurosci; 2007 May; 25(9):2773-82. PubMed ID: 17459108
[TBL] [Abstract][Full Text] [Related]
20. The differential contractile responses to capsaicin and anandamide in muscle strips isolated from the rat urinary bladder.
Saitoh C; Kitada C; Uchida W; Chancellor MB; de Groat WC; Yoshimura N
Eur J Pharmacol; 2007 Sep; 570(1-3):182-7. PubMed ID: 17586490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
